Statewide Opioid Settlement Initiatives

In response to the requirements of Senate Bill 1827, passed by the 87th Texas Legislature in 2021, the Texas Comptroller of Public Accounts publishes statewide opioid settlement agreement records.1

SB 1827 requires the state to maintain an account and a fund related to opioid abatement settlements. The account and fund are used to manage payments received by the state from settlements against opioid manufacturers, distributors, or other parties subject to violation of state or federal laws on the manufacture, marketing, distribution, or sale of opioids.2

Texas Opioid Abatement Council

The Texas Opioid Abatement Fund Council was formed to ensure that money recovered through the joint efforts of the state and its political subdivisions through a statewide opioid settlement agreement is allocated fairly and spent to remediate the opioid crisis using efficient, cost-effective methods.3

The council is administratively attached to the Texas Comptroller’s office, which provides the staff and facilities as necessary to assist the council in performing its duties.4

The council is composed of 14 members, including:5

  • six regional members appointed by the executive commissioner of the Health and Human Services Commission from a list of qualified persons recommended by the respective local governments;
  • one member each appointed by the governor, lieutenant governor, speaker of the House of Representatives and the Texas attorney general;
  • one member employed by a hospital district and appointed by the governor;
  • one member employed by a hospital district and appointed by the attorney general;
  • one member experienced in opioid-related harms who is employed by a law enforcement agency and appointed by the governor; and
  • one non-voting member who serves as the presiding officer of the council and is the comptroller, or the comptroller's designee.

Settlement Agreement Records and Related Documents

Texas has participated in the following agreements with different companies to resolve legal claims against them for their role in the opioid crisis. Funding is dependent on the number of subdivisions or local governments that join the settlement agreements. The companies include opioid manufacturer Johnson & Johnson (“Janssen”), and pharmaceutical distributors AmerisourceBergen, Cardinal Health, and McKesson. Below are the documents related to these agreements.